- EDUW 1 – 14.00-15.00 SIEMENS
Title: High Sensitivity cardiac Troponin I: Central lab or POC, the choice is yours
Chair: Alessandro Ortisi – Siemens Healthineers, Associate Director Global Clinical Marketing
Johannes Neumann, MD – Department of Cardiology, University Heart and Vascular Center Hamburg, German Center for Cardiovascular Research (DZHK), Hamburg, Germany
– Evaluation of patients with suspected myocardial infarction
Nils A. Sörensen MD – Department of Cardiology, University Heart and Vascular Center Hamburg, German Center for Cardiovascular Research (DZHK), Hamburg, Germany
– High-sensitivity point-of-care troponin testingLearning Objectives
• Understand diagnostic steps required in patients with suspected myocardial infarction
• Learn about diagnostic algorithms using high-sensitivity troponin assays
• Learn about novel diagnostic strategies using point-of-care assays
- EDUW 2 – 14.00-15.00 BECKMAN
Title: INTELLIGENT AUTOMATION FOR ALL – Advanced intelligent automation provides laboratories of all sizes with total process control and improved workflow
Prof. Wolfgang Korte, St. Gallen, Switzerland
Automation in large size laboratories and lean operations
Dr. Afruj Ruf, managing director at Integrated Pathology Solutions LLP, Airedale NHS Foundation Trust, UK
Challenge that mid size labs are facing and the role of automationLearning objectives:
• Learn how automated workflows can help laboratories of any size conquer their most pressing challenges
• Discover how laboratories of any size can utilize workflow automation to reduce pre-analytical errors, provide efficient and consistent turnaround times while delivering accurate results
• Note on key differences between an automated workflow and integrated workcell approach to improving laboratory performance.
• Practical considerations when investing in lab automation and how to overcome barriers to implementation
- EDUW 3 – 14.00-15.00 ABBOTT
Title: Novel Blood Tests for Game-Changing Detection and Treatment of Traumatic Brain Injury
Peter Biberthaler, MD – Chair, Department of Trauma Surgery, Technical University Munich
Bernhard Meyer, MD – Chair, Department of Neurosurgery, Technical University Munich
Moderator: Beth McQuiston, MD – Senior Medical Director, Abbott
• Recognize the crucial unmet need for improved brain health assessment
• Appreciate the objective value of GFAP (Glial Fibrillary Acidic Protein) and UCH-L1 (plasma ubiquitin C-terminal hydrolase-L1) as new game-changing tests that help clinicians evaluate the brain and optimize care pathways for traumatic brain injury
• Identify collaborative opportunities to achieve measurably better outcomes related to TBI (Traumatic Brain Injury) for patients, payors clinicians and health systems.
- EDUW 4 – 14.00-15.00 SYSMEX
Title: Providing clinical answers with innovative technology
Chair: Dr. Anja Wevelsiep – Sysmex Europe GmbH
PD Dr. Mathias Zimmermann, DRK Kliniken Berlin, Germany
Prof. Johan Elf, University Uppsala, Sweden
Learning objectives: Sysmex as an IVD manufacturer is aware about diagnostic challenges of clinicians’ in everyday routine. This workshop will review the current practice in infection diagnostics (performance and availability of biomarkers and lab tests) and present products and technologies from haematology and point-of care that can close gaps in diagnostic information. The learning objective is to create awareness for already available and future innovative products with the aim to improve healthcare.
- EDUW 5 – 14.00-15.00 ROCHE
Title: Pandemic Preparedness
Chair: Dr. Christian Simon, Roche Diagnostics
Prof. Dr. Med. Michael Hölscher, Global Health & Infectious Diseases at the Medical Center of the University of Munich
“Fighting Emerging Pathogens – the COVID Pandemic response in Germany”
Speaker: Prof.Dr.med. Stefan Holdenrieder, Director of the Institute of Laboratory Medicine, German Heart Center of the Technical University Munich
“Diagnostic follow-up in a post vaccine setting”
- EDUW 6 – 15.30-16.30 MINDRAY
Title: The pre-classification of digitized images from peripheral blood
Chairs: Giuseppe D’Onofrio – Università Cattolica del Sacro Cuore, Rome, Italy
Min Zheng – Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China
Gina Zini – Department of Imaging Diagnostics, Oncological Radiotherapy and Hematology (Rome)
Title: The pre-classification of digitized images from peripheral blood
Morphological evaluation of peripheral blood (PB) and bone marrow (BM) blood cells through optical microscopic (OM) examination remains a cornerstone in hematological diagnosis.
The development of digitized cell images technology and the current availability of systems capable of pre-classifying digitized blood cell images from PB smears offers practical possibilities of clinical applications and new opportunities in the hematology laboratory practice.
In this workshop comparison between morphology under OM and digitized morphology pre-classification on PB smears from onco-hematological patients will be presented.
- EDUW 7 – 15.30-16.30 SYSMEX
Title: Let your lab work flow. Striving for operational excellence.
Chair: Maros Heidinger – Sysmex Europe GmbH
Rexhina Cipi, Germany – Sysmex Europe GmbH
Johanna Engelage, Germany – Sysmex Europe GmbH
Tanja Tornow, Germany – Sysmex Europe GmbH
When designing a specific work area in the laboratory, one of the challenges is to consider the surrounding processes while targeting their significant improvement, and the selection of a specific analyser configuration best possible supporting the key improvement points and KPIs defined by the laboratory. For decades, the Lean methodology has offered the respective tools and procedures for identifying and eliminating waste in processes. This workshop demonstrates the application of the Lean methodology to specific work areas with the aim to identify optimisation potential by eliminating waste and present solutions specifically addressing the identified optimisation potential.
- EDUW 8 – 15.30-16.30 WATERS
- EDUW 9 – 15.30-16.30 SNIBE
Title: New insights in immunoassays
Chair: Prof. Mario Plebani
Prof. Mario Plebani (Department of Laboratory Medicine, University Hospital of Padova, Italy)
Lecture Title: SARS-CoV- 2 antibodies testing: why, when and how?
Prof. János Kappelmayer (Department of Laboratory Medicine, University of Debrecen, Hungary)
Lecture Title: Experience with AMH and Tacrolimus measurements on the MAGLUMI 800 analyzer
The main learning objective of the workshop is to offer an update in the field of immunoassays.
Immunoassays still play a central role in laboratory medicine, but some issues require further efforts:
• Harmonization and standardization
• Immunoassays versus mass spectrometry
• Biological function versus mass concentration: the case of SARS-CoV-2 neutralizing antibodies
- EDUW 15 – 14.00-15.00 ORTHO
Title: Chimeric Antigen Receptor (CAR)-T cell therapy: research findings, clinical applications, and markers to control cytokine release syndrome
Chair / Scientific coordinator: Cecilia Scarponi, EMEA Clinical Liaison, Ortho Clinical Diagnostics
Prof. Álvaro Urbano Ispizua, Director of the Institute of Hematology and Oncology of Hospital Clínic Barcelona and Full Professor of Medicine at the University of Barcelona.
Speech: Chimeric Antigen Receptor (CAR) – T cell therapy: from immunotherapy research to clinical applications in cancer treatment.
Prof. Jonathan Douxfils, Chief Executive Officer QUALIblood, Namur, Belgium
Speech: Laboratory biomarkers for the investigation of CAR-T cells toxicity.
• The immunotherapy: mechanisms of action and targeted hematological malignancies
• The Patient: successful treatments and strategies to overcome side effects
• How laboratory tests can contribute to a favorable patient outcome? Which biomarkers are currently of interest to assess cytokine release syndrome and neurotoxicity associated with CAR-T cell therapy?
- EDUW 16 – 14.00-15.00 BECKMAN
Title: CULTIVATING CULTURE OF LAB INNOVATION
Advancing quantitative measures of monocyte response to infection from academic pursuit to clinical practice
Dr. Cristian Morales Indiano, Core‐Hematology Coordinator. In Laboratori Clínic Metropolitana Nord (LCMN). Hospital Universitari Germans Trias i Pujol, Spain
Prof. Francesco Curcio, University of Udine, UD, Italy
• Current understanding of monocyte hematopathology and technology that enables monocytes quantification
• Clinical evidence that is leading to new applications
• Practical aspects of use in clinical practice across patient presentations and how to overcome barriers to implementation
- EDUW 17 – 14.00-15.00 ABBOTT
Title: Achieving Measurably Better Healthcare… How to get started and achieve success through integrated clinical care initiatives
Director, Scientific Leadership and Education for Abbott, Core Diagnostics Executive Lead, UNIVANTS of Healthcare Excellence Program
Maria Salinas, PhD
Head of Laboratory, Hospital Universitari Saint Joan d’Alacant, Spain- 2020 UNIVANTS of Healthcare Excellence Global Winner
Rana Nabulsi, MD
Head Consultant on Healthcare Quality, Dubai Health Authority, UAE – 2020 UNIVANTS of Healthcare Excellence Awards, Global Distinction and Best of the Middle East
• Recognize, appreciate and emulate critical success factors and key attributes across successful integrated clinical care teams
• Define relevant key performance indicators that can be influenced and impacted by laboratory medicine and pathology leadership
• Highlight successful examples of award-winning best practices related to the Diabetes epidemic and COVID-19 pandemic.
• Identify opportunities to achieve and be recognized for measurably better healthcare performance
- EDUW 18 – 14.00-15.00 SYSMEX
Title: Towards a smarter lab with digitally enhanced solutions
Chair: Theo Hofman – Sysmex Europe GmbH
Jean-Marc Giannoli – Biogroup Laboratories, Neuville-sur-Saône, France
– Value of combining QC and patient results for decision support on analytical performance
Dr. Patrick Cohen – Geneva University Hospital, Switzerland
– Biomedical insights beyond the numbers
Koray Yurdakul, Sysmex Turkey
– Leveraging virtual and mobile learning experiences in healthcare
Learning objectives: In the laboratory of today, besides global challenges, many regulatory and organisational demands impact the daily work. Oftentimes it can be perceived as a burden, but it also gives new opportunities to improve the laboratory’s quality, streamline processes and find ways to do things differently. With digitally enhanced solutions, information from multiple sources can be consolidated easily for a more holistic approach and lead to new insights. In this workshop, the synergy between existing and new cornerstones of monitoring the quality of analytical processes is demonstrated, explained how the use of expert software can support in clinical decision making and in which ways digital learning experiences can bring and maintain the knowledge of the laboratory staff on a high level while saving time and costs and reduce environmental impact.
- EDUW 19 – 14.00-15.00 ROCHE
Title: Diagnostic Innovation Drivers
Chair: Wim van der Helm, Dr.med. Roche Diagnostics
Prof. Dr. med. Michael Vogeser, Institute of Laboratory Medicine, Hospital University of Munich, Germany
“Use of Mass Spectrometry in Clinical Diagnostics”
Prof. Prof. Charlotte Teunissen, Universitair Medische Centra Amsterdam, The Netherlands
” Timely and accurate differential diagnosis of patients with cognitive impairment”
- EDUW 20 – 15.30-16.30 MINDRAY
Title: Presepsin and new generation inflammatory biomarkers in COVID-19 and other infections
Chairs: Massimiliano M. Corsi Romanelli – Università degli Studi di Milano, Milan, Italy
Antonio Brattoli – Mindray Medical Italy S.R.L., Milan, Italy
Emanuela Galliera – Associated Professor – Department of Biomedical Sciences for Health
Title: Presepsin and new generation inflammatory biomarkers in COVID-19 and other infections
The appropriate identification of infection is the basis for effective treatment and control of infective diseases. Presepsin (PSP), an emerging biomarker of infection, has been recently described as early marker of different infections.
This workshop will present the evaluation of Presepsin, in correlation with new inflammatory markers, cytokine storm molecules and current inflammatory parameters (IL-6, IL-10, SuPAR and sRAGE), in order to define a panel of biomarkers that could be useful for a better prognostic prediction of COVID-19 mortality.
- EDUW 21 – 15.30-16.30 GMT Science
Title: Faecal metagenomics analysis made available at the medical lab to empower clinical diagnosis & management
Francisco Guarner – Member of the Digestive System Research Unit, University Hospital Vall d’Hebron; Consultant of Gastroenterology, Teknon Medical Centre, Barcelona, Spain
Joël Doré – Research Director INRAE, Paris, France
– Microbiota: a key player in physiology and pathophysiology
Fay Betsou – Scientific Advisor, Laboratoire National de Santé, Luxembourg
David Petiteau – Translational microbiomics, GMT, Paris, France
– In practice: setting up faecal metagenomics analyses at the medical laboratory
The gut microbiota is now recognized as a novel therapeutic target in many clinical contexts.
However, due to the lack of a reliable tool to characterize it, the proposed treatments can neither be adapted to the specific needs of the patient nor evaluated in terms of response.
The educational workshop will present how analysis of the faecal metagenome at the medical laboratory is now possible thanks to the combination of reliable, standardized and reproducible pre-analytical and analytical techniques with robust bioinformatics methods. By putting in place this solution, , medical laboratories can empower clinical diagnosis and management in various situations, including very common ones at the medical consultation where patients express gut complaints.
- EDUW 22 – 15.30-16.30 SEBIA
Title: What’s new in Minimal Residual Disease testing for Multiple Myeloma?
Chair: Dr. Martijn VAN DUIJN, Erasmus Medical Center, Rotterdam, The Netherlands
Dr. Thomas DEJOIE, Biochemical Laboratory, University Hospital of Nantes, France
– Overview of MRD testing in Myeloma and current needs
Dr. Hans JACOBS, Radboud University Medical Center, Nijmegen, The Netherlands
– Mass spectrometry as a tool for MRD detection in the blood of Myeloma patients
• Why do we need MRD for patients?
• How do we process MRD in 2021?
• Why do we need alternative to the MRD bone marrow evaluation?
• Understand the principle of mass spectrometric measurements of clonotypic peptides
- EDUW 23 – 15.30-16.30 SNIBE
Title: An update on tumor markers from the general aspects to their clinical uses
Chair: Prof. Tomris Ozben
Prof. Tomáš Zima (Institute of Clinical Chemistry & Laboratory Diagnosis. First Faculty of Medicine Charles University Prague – Czech Republic)
Lecture Title: Classification of tumor markers. Characteristics of ideal tumor markers
Prof. Tomris Ozben (Dept. of Clinical Biochemistry, Medical Faculty, University of Akdeniz, Antalya, Turkey)
Lecture Title: Methods to measure tumor markers. Clinical uses of tumor markers for malignant diseases
Tumor markers are used to determine risk, screen for early cancers, establish diagnosis, follow prognosis, predict the efficiency of a specific therapy, and monitor for disease recurrence.
• Classification of tumor markers based on category, origin, structure, biological function in tumor growth or formation
• Characteristics of ideal tumor markers
• Methods to measure tumor markers
• Limitations of tumor marker tests
• Benign conditions associated with rise in tumor markers
Clinical uses of tumor markers for malignant diseases (clinical cases)
- EDUW 26 – 17.00-18.00 SIEMENS
Title: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases
Chair: Moderator: Jean Charles Clouet – Siemens Healthineers, EMEA Clinical Marketing
Professor Jörn M. Schattenberg – Metabolic Liver Research Program, University Medical Center Mainz
• Educate on the current growing burden of disease due to NAFLD/NASH
• Learn how non-invasive testing can help identify patients at risk of NASH progression
• Understand how clinicians can implement available patient pathways to improve referrals and decrease costs
- EDUW 29 – 14.00-15.00 ORTHO
Title: Sustainable Laboratory Medicine: Prepare for the future now!
Chair / Scientific coordinator: Dr. Bernard Gouget, Ph.D – Assistant Professor at the University Hospital in Paris Descartes. Counsellor for public health at the Fédération Hospitalière de France
Professor Damien Gruson – Head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc – Brussels, Belgium
Speech: Sustainable Laboratory Medicine: Myth or reality?
Jordi Trafí-Prats – Senior Director EMEA Marketing at Ortho Clinical Diagnostics
Speech: Sustainable Laboratory Medicine: we all have a role to play.
Outline of the presentation:
In the coming years, the impact of sustainability will be increasingly felt in healthcare. From the implications of legislation to the growing number of environmentally conscious investors, this is a topic which is set to shape the future direction of hospitals, labs and blood banks.
Professor Damien Gruson as a member of the Division on Emerging Technologies of IFCC, is sharing his perspective and will be providing some pragmatic approaches and share experiences from the perspective of the Clinical Laboratory. Jordi Trafí-Prats will demonstrate how the industry can and should contribute to assure Laboratories are equipped with sustainable solutions
- EDUW 30 – 14.00-15.00 BECKMAN
Title: NO TIME TO WASTE – Early recognition of severe infection and risk of sepsis using monocyte distribution width (MDW)
Prof. Dr. Markus A. Weigand
Department of Anesthesiology, Heidelberg University Hospital, Germany
Pr Pierre Hausfater
Hôpital Pitié-Salpêtrière, Emergency Department and University Pierre et Marie Curie, France
• Recognize the consequences of severe infection and sepsis if gone unrecognized early, particularly important in patient presenting with vague signs and symptoms. Barriers / institutional pressures and role of biomarkers
• Gain a foundation of physiology and global evidence on Monocyte Distribution Width (MDW) that’s leading broader use of this novel biomarker
• Integration into standard of care in Emergency Department and patient case studies
- EDUW 31 – 14.00-15.00 ABBOTT
Title: Driving Healthcare Transformation Through Clinical Decision Support
Dr Janne Cadamuro – Department of Laboratory Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria
Title: How to tackle laboratory underuse using Clinical Decision Support Systems (CDSS)
Francoise Luyckx – Pharmacist biologist, Laboratory Manager and Coordinator of new projects, member of the “Artificial Intelligence” working group, Coordinator of CDS project and IT trainer, University Hospital of Liege (CHU de Liège), Belgium
Romy Gadisseur – Pharmacist biologist, Head of the Laboratory of Automated Biochemistry, Department of Clinical Chemistry, University Hospital of Liege (CHU de Liège), Belgium
Title: CHU Liege: Impacting CKD patients by leveraging a Clinical Decision Support
Florian Lange, Director AlinIQ & Enterprise Solutions EMEA
Title: Transformation of healthcare through digital solutions
• Recognize the value of clinical decision support and artificial intelligence in achieving measurable better healthcare.
• Understand how the use of a clinical decision support solution enabled the University Hospital of Salzburg and in CHU Liege to address unmet needs for microcytic anaemia, diabetes and chronic kidney disease.
• Connect the dots on how to get started and drive digital transformation into better healthcare outcomes
- EDUW 32 – 14.00-15.00 SIEMENS
Title: The Evolving Role of Artificial Intelligence in Laboratory Testing
Raj Gopalan, MD, MSIS, Head of Global Clinical Decision Support and Chief Medical Informatics Officer, Siemens Healthineers, Tarrytown, NY, USA
Sarah Wheeler, Assistant Professor, PhD, FACB, CC, Associate Medical Director, Clinical Immunopathology; Medical Director, Automated Laboratory, UPMC Mercy; and Medical Director, Automated Laboratory, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
• Define artificial intelligence and machine learning in the context of laboratory medicine.
• Discuss the relevance of artificial intelligence and machine learning in laboratory medicine and diagnostics.
• Understand the potential value of artificial intelligence in laboratory diagnostics.
- EDUW 33 – 14.00-15.00 ROCHE
Title: Diabets and the heart
Chair: Dr.med. Paul van Haelst, Roche Diagnostics
Muthiah Vaduganathan, MD, MPH, Harvard Medical School, Boston, USA
“Early identification of Heart Failure in T2D; Intervention for improving patient outcomes”
Prof.Dr. Stephan Jacob – Praxis für Prävention und Therapie, Villingen-Schwenningen, Germany
“Integrated Personal Diabetes Management”
- EDUW 35 – 15.30-16.30 BD
Title: Preanalytical POCT Errors – What impact do they have?
Chair: Dr Brendan Meyer
Senior Manager, Medical Affairs Europe, Integrated Diagnostic Solutions, BD Life Sciences
Professor Peter Luppa,
Institute for Clinical Chemistry and Pathobiochemistry, Technische Universität München, Munich, Germany
Dr Andrei Tintu,
Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Dr Antonio Buño Soto
Pathology Department, La Paz Hospital, Madrid, Spain
• There are erroneous POCT results due to blood sample quality, which are not detected by the POCT device.
• How preanalytical errors not detected by the POCT device can impact on patient care.
• POCT preanalytical errors can impact on hospital resources and budgets